Table 1.
Demographic Data
| Any Events | Hard Events | ||||
|---|---|---|---|---|---|
|
| |||||
| Yes | No | Yes | No | ||
|
| |||||
| Patient Characteristics | (n=200) | (n=106) | (n=94) | (n=35) | (n=165) |
| Age, y | 64±11 | 63±11 | 65±11 | 63±10 | 64±11 |
| Men:Women | 130:70 | 68:38 | 62:32 | 26:9 | 104:61 |
| Weight, Kg | 90±20 | 91±21 | 90±19 | 90±20 | 91±20 |
| Height, cm | 170±11 | 170±10 | 171±11 | 170±11 | 170±11 |
| BSA, m2 | 2.06±0.67 | 2.01±0.24 | 2.12±0.99 | 2.01±0.25 | 2.07±0.7 |
| LVEF, % *,** | 43.5±9 | 42±10 | 45±9 | 39±10 | 44±9 |
| WMSI rest ** | 1.71±0.48 | 1.77±0.51 | 1.64±0.45 | 2.01±0.50 | 1.65±0.46 |
| WMSI peak *,** | 1.59±0.50 | 1.68±0.53 | 1.49±0.45 | 1.94±0.52 | 1.52±0.47 |
|
| |||||
| Historical Information | n (%) | n (%) | n (%) | n (%) | n (%) |
| Hypertension | 145(72) | 80(75) | 65(69) | 24(69) | 121(73) |
| Diabetes mellitus | 80(40) | 47(44) | 33(35) | 16(46) | 64(39) |
| COPD | 40(20) | 23(22) | 17(18) | 7(21) | 33(20) |
| Smoking | 89(44) | 48(45) | 41(44) | 16(46) | 73(44) |
| Hypercholesterolemia | 114(57) | 60(57) | 54(57) | 17(49) | 97(59) |
| Prior revascularization (CABG or PTCA) | 114(57) | 59(56) | 55(59) | 19(54 | 95(58) |
| Prior Q-wave MI | 82(41) | 42(40) | 40(43) | 18(51) | 64(39) |
|
| |||||
| Medications | |||||
| B-Blockers | 96(48) | 54(51) | 42(45) | 15(43) | 81(49) |
| Calcium antagonist | 48(24) | 29(27) | 19(20) | 8(23) | 40(24) |
| ASA | 132(66) | 71(67) | 61(65) | 20(57) | 112(68) |
| Nitrate | 78(39) | 43(41) | 35(37) | 14(40) | 64(39) |
| ACE inhibitor * | 75(37) | 49(46) | 26(28) | 16(46) | 59(36) |
| Diuretic * | 102(51) | 64(60) | 38(40) | 23(66) | 79(48) |
Abbreviations: BSA, body surface area; CABG, coronary artery bypass graft; BMI, body mass index; COPD, chronic obstructive pulmonary disease; LVEF, left ventricule ejection fraction; WMSI, wall motion score index; PTCA, percutaneous transluminal coronary angioplasty;
*
p<0.05 any events yes vs. no;
**
p<0.05 hard events yes vs. no